Bayer Aktiengesellschaft (ETR:BAYN – Get Free Report) fell 1.2% on Thursday . The company traded as low as €26.27 and last traded at €26.43. 1,390,189 shares traded hands during mid-day trading, The stock had previously closed at €26.76.
Bayer Aktiengesellschaft Stock Performance
The company has a market capitalization of $26.30 billion, a price-to-earnings ratio of -29.89, a PEG ratio of 36.39 and a beta of 0.97. The business has a 50-day simple moving average of €27.67 and a two-hundred day simple moving average of €26.56.
About Bayer Aktiengesellschaft
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
Read More
- Five stocks we like better than Bayer Aktiengesellschaft
- Compound Interest and Why It Matters When Investing
- Rivian’s Chart Says Go, But Some Analysts Still Say No
- Short Selling – The Pros and Cons
- e.l.f. Sell-Off Is a Good Time to Buy, According to Analysts
- What is the MACD Indicator and How to Use it in Your Trading
- T-Mobile Is The Most Oversold Mega-Cap Stock—Time to Buy?
Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
